Formononetin reverses immune-mediated TregTh17 immune imbalance in Immune-mediated bone marrow failure mice by regulating the PI3KAkt signaling pathway

preprint OA: closed CC-BY-4.0
📄 Open PDF Full text JSON View at publisher
AI-generated summary by claude@2026-07+body, 2026-07-05

Formononetin reversed immune-mediated bone marrow failure in mice by increasing Treg cells, decreasing Th17 cells, and regulating the PI3K/Akt signaling pathway.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

AI-generated deep summary by claude@2026-07, 2026-07-05 · read from full text

The study investigated whether formononetin (FMN) can ameliorate immune-mediated bone marrow failure in a mouse model of severe aplastic anemia, focusing on CD4+ Treg and Th17 cell balance and the PI3K/Akt signaling pathway. Mice were irradiated and infused with lymphocytes to induce immune-mediated BMF, then treated for 10 days with FMN (low/high dose) or cyclosporine A; Treg/Th17 frequencies in bone marrow and spleen were measured by flow cytometry, and PI3K/Akt protein levels were assessed by immunohistochemistry and western blotting, with in vitro differentiation of naive CD4+ T cells into Tregs evaluated by flow cytometry and ELISA. FMN treatment increased red blood cells, hemoglobin, and platelets, restored T cell subset imbalance by increasing Treg and decreasing Th17 cells, and reduced PI3K and Akt expression levels, whereas the model group showed decreased Tregs and increased Th17s. As a caveat, the work is reported as a preprint and has not been peer reviewed. The paper does not explicitly discuss endometriosis or adenomyosis; it was included in the corpus via a keyword match in the upstream search index.

Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works

Abstract

Abstract Background: Severe aplastic anemia (SAA) is a syndrome of bone marrow failure which is life-threatening. Recent research has discovered that CD4+ T cell subsets, including Treg cells and Th17 cells, play a pivotal role in the pathogenesis of SAA. Formononetin (FMN) is a natural compound extracted from the traditional Chinese medicine Huangqi, which has the ability to regulate the imbalance of Treg/Th17 cells in some inflammatory diseases. Nevertheless, the therapeutic effect of FMN in SAA has yet to be definitively established. Therefore, the objective of this research was to investigate the effect of FMN on SAA and elucidate its underlying mechanism. Methods: In vivo experiments, the mice were divided into five groups: the control group, model group, low- and high- dose of FMN groups and positive control cyclosporine A group. The immune-mediated bone marrow failure (BMF) mouse model was established by the total body X-ray radiation and lymphocyte infusion. After 10 days of continuous administration of FMN, the numbers of Treg/Th17 cells in the bone marrow and spleen were assessed by flow cytometry. The protein expressions of PI3K/Akt pathway in the bone marrow and spleen was assessed by immunohistochemistry and western blotting. In vitro, the impact of FMN on the differentiation of naive CD4+T cells into Treg cells was investigated by flow cytometry and ELISA. Results: In comparison with the control group, the model group showed a reduction in bone marrow nucleated cells, a significant decrease in peripheral blood cells, and an altered CD8+/CD4+T cell ratio. These findings indicate the successful establishment of a mouse model of immune-mediated BMF. After FMN treatment, there were the increased levels of red blood cells, hemoglobin and platelets. In addition, FMN mitigated the bone marrow destruction and restored the CD8+/CD4+ T cell ratio. Furthermore, in comparison with the control group, the model group showed the decreased levels of Treg cells and the increased levels of Th17 cells. After FMN treatment, there was a significantly increased number of Treg cells and a decreased number of Th17 cells. Additionally, FMN remarkably down-regulated the expression levels of PI3K and Akt proteins in immune-mediated BMF mice. Conclusions: FMN alleviates immune-mediated BMF by modulating the balance of Treg/Th17 cells through the PI3K/Akt signaling pathway.
Full text 15,118 characters · extracted from preprint-html · click to expand
Formononetin reverses immune-mediated TregTh17 immune imbalance in Immune-mediated bone marrow failure mice by regulating the PI3KAkt signaling pathway | Research Square window.SnipcartSettings = { analytics: { enabled: false } }; (function() { var accessVector = localStorage.getItem('access_vector') || ''; window.dataLayer = window.dataLayer || []; if (accessVector) { window.dataLayer.push({ user: { profile: { profileInfo: { snid: accessVector } } } }); } })(); (function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start':new Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0],j=d.createElement(s),dl=l!='dataLayer'?'&l='+l:'';j.async=true;j.src='https://www.googletagmanager.com/gtm.js?id='+i+dl;f.parentNode.insertBefore(j,f);})(window,document,'script','dataLayer','GTM-K279D39R'); Browse Preprints In Review Journals COVID-19 Preprints AJE Video Bytes Research Tools Research Promotion AJE Professional Editing AJE Rubriq About Preprint Platform In Review Editorial Policies Our Team Advisory Board Help Center Sign In Submit a Preprint Cite Share Download PDF Research Article Formononetin reverses immune-mediated TregTh17 immune imbalance in Immune-mediated bone marrow failure mice by regulating the PI3KAkt signaling pathway hui xuan lan, Wei Qiu, Jie Wu, Zhijing Hu, Xiaomin Zhang, lingling zhu This is a preprint; it has not been peer reviewed by a journal. https://doi.org/ 10.21203/rs.3.rs-3463325/v1 This work is licensed under a CC BY 4.0 License Status: Published Journal Publication published 25 Mar, 2024 Read the published version in Chinese Medicine → Version 1 posted 5 You are reading this latest preprint version Abstract Background: Severe aplastic anemia (SAA) is a syndrome of bone marrow failure which is life-threatening. Recent research has discovered that CD4+ T cell subsets, including Treg cells and Th17 cells, play a pivotal role in the pathogenesis of SAA. Formononetin (FMN) is a natural compound extracted from the traditional Chinese medicine Huangqi, which has the ability to regulate the imbalance of Treg/Th17 cells in some inflammatory diseases. Nevertheless, the therapeutic effect of FMN in SAA has yet to be definitively established. Therefore, the objective of this research was to investigate the effect of FMN on SAA and elucidate its underlying mechanism. Methods: In vivo experiments, the mice were divided into five groups: the control group, model group, low- and high- dose of FMN groups and positive control cyclosporine A group. The immune-mediated bone marrow failure (BMF) mouse model was established by the total body X-ray radiation and lymphocyte infusion. After 10 days of continuous administration of FMN, the numbers of Treg/Th17 cells in the bone marrow and spleen were assessed by flow cytometry. The protein expressions of PI3K/Akt pathway in the bone marrow and spleen was assessed by immunohistochemistry and western blotting. In vitro, the impact of FMN on the differentiation of naive CD4+T cells into Treg cells was investigated by flow cytometry and ELISA. Results: In comparison with the control group, the model group showed a reduction in bone marrow nucleated cells, a significant decrease in peripheral blood cells, and an altered CD8+/CD4+T cell ratio. These findings indicate the successful establishment of a mouse model of immune-mediated BMF. After FMN treatment, there were the increased levels of red blood cells, hemoglobin and platelets. In addition, FMN mitigated the bone marrow destruction and restored the CD8+/CD4+ T cell ratio. Furthermore, in comparison with the control group, the model group showed the decreased levels of Treg cells and the increased levels of Th17 cells. After FMN treatment, there was a significantly increased number of Treg cells and a decreased number of Th17 cells. Additionally, FMN remarkably down-regulated the expression levels of PI3K and Akt proteins in immune-mediated BMF mice. Conclusions: FMN alleviates immune-mediated BMF by modulating the balance of Treg/Th17 cells through the PI3K/Akt signaling pathway. Formononetin Treg/Th17 cells Severe aplastic anemia PI3K/Akt signaling pathway Full Text Cite Share Download PDF Status: Published Journal Publication published 25 Mar, 2024 Read the published version in Chinese Medicine → Version 1 posted Editorial decision: Major revision 07 Dec, 2023 Reviewers agreed at journal 13 Nov, 2023 Reviewers invited by journal 02 Nov, 2023 Editor assigned by journal 01 Nov, 2023 First submitted to journal 21 Oct, 2023 You are reading this latest preprint version Research Square lets you share your work early, gain feedback from the community, and start making changes to your manuscript prior to peer review in a journal. As a division of Research Square Company, we’re committed to making research communication faster, fairer, and more useful. We do this by developing innovative software and high quality services for the global research community. Our growing team is made up of researchers and industry professionals working together to solve the most critical problems facing scientific publishing. Also discoverable on Platform About Our Team In Review Editorial Policies Advisory Board Help Center Resources Author Services Accessibility API Access RSS feed Manage Cookie Preferences © Research Square 2026 | ISSN 2693-5015 (online) Privacy Policy Terms of Service Do Not Sell My Personal Information {"props":{"pageProps":{"initialData":{"identity":"rs-3463325","acceptedTermsAndConditions":true,"allowDirectSubmit":false,"archivedVersions":[],"articleType":"Research Article","associatedPublications":[],"authors":[{"id":245460521,"identity":"c2fc6eb8-4b58-4719-a1b3-8d0d7508093b","order_by":0,"name":"hui xuan lan","email":"","orcid":"","institution":"Southern Medical University","correspondingAuthor":false,"prefix":"","firstName":"hui","middleName":"xuan","lastName":"lan","suffix":""},{"id":245460522,"identity":"5dfb8de1-d6e6-45f4-b84d-8f6b25b3cd91","order_by":1,"name":"Wei Qiu","email":"","orcid":"","institution":"Southern Medical University","correspondingAuthor":false,"prefix":"","firstName":"Wei","middleName":"","lastName":"Qiu","suffix":""},{"id":245460523,"identity":"7f2b8648-00c4-4bf2-b703-609dd7f12a31","order_by":2,"name":"Jie Wu","email":"","orcid":"","institution":"Southern Medical University","correspondingAuthor":false,"prefix":"","firstName":"Jie","middleName":"","lastName":"Wu","suffix":""},{"id":245460524,"identity":"353d0770-7ec2-4040-b3c4-dd429a310324","order_by":3,"name":"Zhijing Hu","email":"","orcid":"","institution":"Southern Medical University","correspondingAuthor":false,"prefix":"","firstName":"Zhijing","middleName":"","lastName":"Hu","suffix":""},{"id":245460525,"identity":"252cde9b-a30d-4493-a16a-6a3dd417eafc","order_by":4,"name":"Xiaomin Zhang","email":"","orcid":"","institution":"Shenzhen University Health Science Center","correspondingAuthor":false,"prefix":"","firstName":"Xiaomin","middleName":"","lastName":"Zhang","suffix":""},{"id":245460526,"identity":"e43ad7da-7914-456c-98ff-61a651b8ac02","order_by":5,"name":"lingling zhu","email":"data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAAZAAAAAyAQMAAABI0h/eAAAABlBMVEX///8AAABVwtN+AAAACXBIWXMAAA7EAAAOxAGVKw4bAAAAxElEQVRIiWNgGAWjYDACCQbGAw8MJOTk2RsbH34gUgvDgYQKC2PDnsPNxhLEazlTkdhwI71NgIcYHfKzewwOJLZJMDbOfNgG1G8np9tAQAvjnDNgLczs0oltDwoYko3NDhDQwiyRA9bCxjg7sd1AguFA4jZCWtigWngYbh4EkURo4QFpSTgjIcFwg5FILRISaQXAQJYwMOxJBAayARF+kZ+RvPHBB4O6+vnsxx8+/FBhJ0dQCxowIE35KBgFo2AUjAIcAABIXUN8x6jZbwAAAABJRU5ErkJggg==","orcid":"https://orcid.org/0000-0002-8982-0579","institution":"Southern Medical University","correspondingAuthor":true,"prefix":"","firstName":"lingling","middleName":"","lastName":"zhu","suffix":""}],"badges":[],"createdAt":"2023-10-18 18:05:17","currentVersionCode":1,"declarations":"","doi":"10.21203/rs.3.rs-3463325/v1","doiUrl":"https://doi.org/10.21203/rs.3.rs-3463325/v1","draftVersion":[],"editorialEvents":[{"content":"https://doi.org/10.1186/s13020-024-00919-9","type":"published","date":"2024-03-25T15:00:36+00:00"}],"editorialNote":"","failedWorkflow":false,"files":[{"id":53869566,"identity":"48d63015-bb37-477e-8a45-4157b9c00d96","added_by":"auto","created_at":"2024-04-01 15:10:13","extension":"pdf","order_by":1,"title":"","display":"","copyAsset":false,"role":"manuscript-pdf","size":1326886,"visible":true,"origin":"","legend":"","description":"","filename":"manuscript.pdf","url":"https://assets-eu.researchsquare.com/files/rs-3463325/v1_covered_9e87d0ff-dc72-4aa6-9ad5-a8065e31284d.pdf"}],"financialInterests":"","formattedTitle":"Formononetin reverses immune-mediated TregTh17 immune imbalance in Immune-mediated bone marrow failure mice by regulating the PI3KAkt signaling pathway","fulltext":[],"fulltextSource":"","fullText":"","funders":[],"hasAdminPriorityOnWorkflow":false,"hasManuscriptDocX":false,"hasOptedInToPreprint":true,"hasPassedJournalQc":"","hasAnyPriority":false,"hideJournal":false,"highlight":"","institution":"","isAcceptedByJournal":true,"isAuthorSuppliedPdf":true,"isDeskRejected":"","isHiddenFromSearch":false,"isInQc":false,"isInWorkflow":true,"isPdf":true,"isPdfUpToDate":true,"isWithdrawnOrRetracted":false,"journal":{"display":true,"email":"[email protected]","identity":"chinese-medicine","isNatureJournal":false,"hasQc":true,"allowDirectSubmit":false,"externalIdentity":"cmed","sideBox":"Learn more about [Chinese Medicine](http://cmjournal.biomedcentral.com)","snPcode":"","submissionUrl":"https://www.editorialmanager.com/cmed/default.aspx","title":"Chinese Medicine","twitterHandle":"@BioMedCentral","acdcEnabled":true,"dfaEnabled":true,"editorialSystem":"em","reportingPortfolio":"BMC/SO AJ","inReviewEnabled":true,"inReviewRevisionsEnabled":true},"keywords":"Formononetin, Treg/Th17 cells, Severe aplastic anemia, PI3K/Akt signaling pathway","lastPublishedDoi":"10.21203/rs.3.rs-3463325/v1","lastPublishedDoiUrl":"https://doi.org/10.21203/rs.3.rs-3463325/v1","license":{"name":"CC BY 4.0","url":"https://creativecommons.org/licenses/by/4.0/"},"manuscriptAbstract":"\u003cp\u003eBackground: Severe aplastic anemia (SAA) is a syndrome of bone marrow failure which is life-threatening. Recent research has discovered that CD4+ T cell subsets, including Treg cells and Th17 cells, play a pivotal role in the pathogenesis of SAA. Formononetin (FMN) is a natural compound extracted from the traditional Chinese medicine Huangqi, which has the ability to regulate the imbalance of Treg/Th17 cells in some inflammatory diseases. Nevertheless, the therapeutic effect of FMN in SAA has yet to be definitively established. Therefore, the objective of this research was to investigate the effect of FMN on SAA and elucidate its underlying mechanism.\u0026nbsp;\u003c/p\u003e\n\u003cp\u003eMethods: In vivo experiments, the mice were divided into five groups: the control group, model group, low- and high- dose of FMN groups and positive control cyclosporine A group. The immune-mediated bone marrow failure (BMF) mouse model was established by the total body X-ray radiation and lymphocyte infusion. After 10 days of continuous administration of FMN, the numbers of Treg/Th17 cells in the bone marrow and spleen were assessed by flow cytometry. The protein expressions of PI3K/Akt pathway in the bone marrow and spleen was assessed by immunohistochemistry and western blotting. In vitro, the impact of FMN on the differentiation of naive CD4+T cells into Treg cells was investigated by flow cytometry and ELISA.\u0026nbsp;\u003c/p\u003e\n\u003cp\u003eResults: In comparison with the control group, the model group showed a reduction in bone marrow nucleated cells, a significant decrease in peripheral blood cells, and an altered CD8+/CD4+T cell ratio. These findings indicate the successful establishment of a mouse model of immune-mediated BMF. After FMN treatment, there were the increased levels of red blood cells, hemoglobin and platelets. In addition, FMN mitigated the bone marrow destruction and restored the CD8+/CD4+ T cell ratio. Furthermore, in comparison with the control group, the model group showed the decreased levels of Treg cells and the increased levels of Th17 cells. After FMN treatment, there was a significantly increased number of Treg cells and a decreased number of Th17 cells. Additionally, FMN remarkably down-regulated the expression levels of PI3K and Akt proteins in immune-mediated BMF mice.\u0026nbsp;\u003c/p\u003e\n\u003cp\u003eConclusions: FMN alleviates immune-mediated BMF by modulating the balance of Treg/Th17 cells through the PI3K/Akt signaling pathway.\u003c/p\u003e","manuscriptTitle":"Formononetin reverses immune-mediated TregTh17 immune imbalance in Immune-mediated bone marrow failure mice by regulating the PI3KAkt signaling pathway","msid":"","msnumber":"","nonDraftVersions":[{"code":1,"date":"2023-11-07 15:55:59","doi":"10.21203/rs.3.rs-3463325/v1","editorialEvents":[{"type":"communityComments","content":0},{"type":"decision","content":"Major revision","date":"2023-12-07T05:50:30+00:00","index":"","fulltext":""},{"type":"reviewerAgreed","content":"","date":"2023-11-13T06:50:04+00:00","index":0,"fulltext":""},{"type":"reviewersInvited","content":"","date":"2023-11-03T03:45:47+00:00","index":"","fulltext":""},{"type":"editorAssigned","content":"","date":"2023-11-02T03:58:31+00:00","index":"","fulltext":""},{"type":"submitted","content":"Chinese Medicine","date":"2023-10-22T03:10:20+00:00","index":"","fulltext":""}],"status":"published","journal":{"display":true,"email":"[email protected]","identity":"chinese-medicine","isNatureJournal":false,"hasQc":true,"allowDirectSubmit":false,"externalIdentity":"cmed","sideBox":"Learn more about [Chinese Medicine](http://cmjournal.biomedcentral.com)","snPcode":"","submissionUrl":"https://www.editorialmanager.com/cmed/default.aspx","title":"Chinese Medicine","twitterHandle":"@BioMedCentral","acdcEnabled":true,"dfaEnabled":true,"editorialSystem":"em","reportingPortfolio":"BMC/SO AJ","inReviewEnabled":true,"inReviewRevisionsEnabled":true}}],"origin":"","ownerIdentity":"1d5f959d-234e-438c-9c8b-5610f56f27bd","owner":[],"postedDate":"November 7th, 2023","published":true,"recentEditorialEvents":[],"rejectedJournal":[],"revision":"","amendment":"","status":"published-in-journal","subjectAreas":[],"tags":[],"updatedAt":"2024-04-01T15:04:38+00:00","versionOfRecord":{"articleIdentity":"rs-3463325","link":"https://doi.org/10.1186/s13020-024-00919-9","journal":{"identity":"chinese-medicine","isVorOnly":false,"title":"Chinese Medicine"},"publishedOn":"2024-03-25 15:00:36","publishedOnDateReadable":"March 25th, 2024"},"versionCreatedAt":"2023-11-07 15:55:59","video":"","vorDoi":"10.1186/s13020-024-00919-9","vorDoiUrl":"https://doi.org/10.1186/s13020-024-00919-9","workflowStages":[]},"version":"v1","identity":"rs-3463325","journalConfig":"researchsquare"},"__N_SSP":true},"page":"/article/[identity]/[[...version]]","query":{"redirect":"/article/rs-3463325","identity":"rs-3463325","version":["v1"]},"buildId":"J0_U0BvcaRcwD8yVFaRlm","isFallback":false,"isExperimentalCompile":false,"dynamicIds":[84888],"gssp":true,"scriptLoader":[]}

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

Ask this paper AI returns verbatim quotes from the full text · source: preprint-html

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.

Source provenance

europepmc
last seen: 2026-05-19T01:45:01.086888+00:00
unpaywall
last seen: 2026-05-27T02:00:06.600101+00:00
License: CC-BY-4.0